Literature DB >> 10521292

Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia.

I Quack1, B Vonderstrass, M Stock, A S Aylsworth, A Becker, L Brueton, P J Lee, F Majewski, J B Mulliken, M Suri, M Zenker, S Mundlos, F Otto.   

Abstract

Cleidocranial dysplasia (CCD) is a dominantly inherited disorder characterized by patent fontanelles, wide cranial sutures, hypoplasia of clavicles, short stature, supernumerary teeth, and other skeletal anomalies. We recently demonstrated that mutations in the transcription factor CBFA1, on chromosome 6p21, are associated with CCD. We have now analyzed the CBFA1 gene in 42 unrelated patients with CCD. In 18 patients, mutations were detected in the coding region of the CBFA1 gene, including 8 frameshift, 2 nonsense, and 9 missense mutations, as well as 2 novel polymorphisms. A cluster of missense mutations at arginine 225 (R225) identifies this residue as crucial for CBFA1 function. In vitro green fluorescent protein fusion studies show that R225 mutations interfere with nuclear accumulation of CBFA1 protein. There is no phenotypic difference between patients with deletions or frameshifts and those with other intragenic mutations, suggesting that CCD is generally caused by haploinsufficiency. However, we were able to extend the CCD phenotypic spectrum. A missense mutation identified in one family with supernumerary teeth and a radiologically normal skeleton indicates that mutations in CBFA1 can be associated exclusively with a dental phenotype. In addition, one patient with severe CCD and a frameshift mutation in codon 402 had osteoporosis leading to recurrent bone fractures and scoliosis, providing first evidence that CBFA1 may help maintain adult bone, in addition to its function in bone development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10521292      PMCID: PMC1288279          DOI: 10.1086/302622

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

Review 1.  Cleidocranial dysplasia: clinical and molecular genetics.

Authors:  S Mundlos
Journal:  J Med Genet       Date:  1999-03       Impact factor: 6.318

2.  A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development.

Authors:  P Ducy; M Starbuck; M Priemel; J Shen; G Pinero; V Geoffroy; M Amling; G Karsenty
Journal:  Genes Dev       Date:  1999-04-15       Impact factor: 11.361

3.  AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization.

Authors:  D Levanon; V Negreanu; Y Bernstein; I Bar-Am; L Avivi; Y Groner
Journal:  Genomics       Date:  1994-09-15       Impact factor: 5.736

4.  Mouse clavicular development: analysis of wild-type and cleidocranial dysplasia mutant mice.

Authors:  L F Huang; N Fukai; P B Selby; B R Olsen; S Mundlos
Journal:  Dev Dyn       Date:  1997-09       Impact factor: 3.780

5.  Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function.

Authors:  V Geoffroy; D A Corral; L Zhou; B Lee; G Karsenty
Journal:  Mamm Genome       Date:  1998-01       Impact factor: 2.957

6.  Regulation of chondrocyte differentiation by Cbfa1.

Authors:  I S Kim; F Otto; B Zabel; S Mundlos
Journal:  Mech Dev       Date:  1999-02       Impact factor: 1.882

7.  Human homologs of a Drosophila Enhancer of split gene product define a novel family of nuclear proteins.

Authors:  S Stifani; C M Blaumueller; N J Redhead; R E Hill; S Artavanis-Tsakonas
Journal:  Nat Genet       Date:  1992-10       Impact factor: 38.330

8.  Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor.

Authors:  Z S Xiao; R Thomas; T K Hinson; L D Quarles
Journal:  Gene       Date:  1998-07-03       Impact factor: 3.688

9.  Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta.

Authors:  K Thirunavukkarasu; M Mahajan; K W McLarren; S Stifani; G Karsenty
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

10.  Mutations affecting segment number and polarity in Drosophila.

Authors:  C Nüsslein-Volhard; E Wieschaus
Journal:  Nature       Date:  1980-10-30       Impact factor: 49.962

View more
  55 in total

1.  Immortalized mouse floxed Bmp2 dental papilla mesenchymal cell lines preserve odontoblastic phenotype and respond to BMP2.

Authors:  Li-an Wu; Junsheng Feng; Lynn Wang; Yan-dong Mu; Andrew Baker; Kevin J Donly; Jelica Gluhak-Heinrich; Stephen E Harris; Mary MacDougall; Shuo Chen
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

2.  Development and characterization of a mouse floxed Bmp2 osteoblast cell line that retains osteoblast genotype and phenotype.

Authors:  Li-an Wu; Junsheng Feng; Lynn Wang; Yan-dong Mu; Andrew Baker; Kevin J Donly; Stephen E Harris; Mary MacDougall; Shuo Chen
Journal:  Cell Tissue Res       Date:  2011-01-27       Impact factor: 5.249

Review 3.  Genetic disorders of the skeleton: a developmental approach.

Authors:  Uwe Kornak; Stefan Mundlos
Journal:  Am J Hum Genet       Date:  2003-07-31       Impact factor: 11.025

4.  Severe cleidocranial dysplasia and hypophosphatasia in a child with microdeletion of the C-terminal region of RUNX2.

Authors:  Areeg H El-Gharbawy; Joseph N Peeden; Ralph S Lachman; John M Graham; Stephen R Moore; David L Rimoin
Journal:  Am J Med Genet A       Date:  2010-01       Impact factor: 2.802

Review 5.  microRNA Regulation of Skeletal Development.

Authors:  Steven R Sera; Nicole I Zur Nieden
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

6.  [Anomalies of the skull in cleidocranial dysplasia].

Authors:  I Golan; A Waldeck; U Baumert; J Strutz; D Müssig
Journal:  HNO       Date:  2004-12       Impact factor: 1.284

7.  Serine phosphorylation of RUNX2 with novel potential functions as negative regulatory mechanisms.

Authors:  Hee-Jun Wee; Gang Huang; Katsuya Shigesada; Yoshiaki Ito
Journal:  EMBO Rep       Date:  2002-09-13       Impact factor: 8.807

8.  [Immunohistochemical study on collagen I content in the gingiva in cleidocranial dysplasia].

Authors:  Tobias Ach; Uwe Baumert; Christian Morsczeck; Regine Dahse; Torsten Eugen Reichert; Oliver Driemel
Journal:  Mund Kiefer Gesichtschir       Date:  2007-12

9.  The role of periodontal ligament cells in delayed tooth eruption in patients with cleidocranial dysostosis.

Authors:  Stefan Lossdörfer; Bassel Abou Jamra; Birgit Rath-Deschner; Werner Götz; Rami Abou Jamra; Bert Braumann; Andreas Jäger
Journal:  J Orofac Orthop       Date:  2009-12-04       Impact factor: 1.938

10.  RUNX2 mutations in Chinese patients with cleidocranial dysplasia.

Authors:  Yalin Li; Wei Pan; Wanfeng Xu; Nan He; Xuewu Chen; Hong Liu; L Darryl Quarles; Honghao Zhou; Zhousheng Xiao
Journal:  Mutagenesis       Date:  2009-06-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.